Dr. Zausner Skarbnik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
125 Queens Rd
suite 600
Charlotte, NC 28204- Is this information wrong?
Education & Training
- City of Hope Comprehensive Cancer CenterAdult Hematopoietic Stem Cell Transplantation, 2013 - 2014
- Temple University HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
- Universidade de Sao Paulo Faculty of MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2013 - Present
- NC State Medical License Active through 2024
- DC State Medical License 2018 - 2020
- NJ State Medical License 2014 - 2019
- PA State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence Start of enrollment: 2016 Jun 07
Publications & Presentations
PubMed
- An indirect comparison of acalabrutinib with and without obinutuzumab versus zanubrutinib in treatment-naive CLL.John N Allan, Dan James, Helen Bridge, Miguel Miranda, Alan Sm Yong, Fady Fam, Jack Roos, Vikram Shetty Dr, Adam S Kittai, Alan P Skarbnik, Matthew S Davids> ;Blood Advances. 2024 Apr 10
- 1 citationsActivity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b tr...Arnon P Kater, Önder Arslan, Fatih Demirkan, Yair Herishanu, Burhan Ferhanoglu, Marcos Gonzalez Diaz, Brian Leber, Marco Montillo, Panayiotis Panayiotidis, Davide Ross...> ;The Lancet. Oncology. 2024 Apr 1
- Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study.Laura Samples, Jenna M Voutsinas MPH, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K G...> ;Blood Advances. 2024 Feb 2
- Join now to see all
Abstracts/Posters
- An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL)Alan Skarbnik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular TherapiesAlan Skarbnik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World PatientsAlan Skarbnik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Professional Memberships
- Member
- Member
- American Society of Blood and Marrow TransplantationMember
Other Languages
- Portuguese, Spanish
Hospital Affiliations
- Novant Health Presbyterian Medical CenterCharlotte, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: